Market revenue in 2022 | USD 1,004.9 million |
Market revenue in 2030 | USD 2,325.8 million |
Growth rate | 11.1% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyvinyl Chloride (PVC) |
Historical data covered | 2019 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 22.24% in 2024. Horizon Databook has segmented the Europe biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
The increasing geriatric population and the rising occurrences of chronic diseases in Europe are expected to surge the demand for biopharma plastic-based medical products in the region. This, in turn, drives the consumption of biopharma plastics used for manufacturing medical products in Europe over the forecast period.
An increase in government investments in the healthcare industry of the region is anticipated to drive the demand for biopharma plastic-based medical products in Europe. This, in turn, is anticipated to have a positive influence on the growth of biopharma plastics market in Europe from 2022 to 2030.
Biopharma plastics are widely used in the healthcare industry for developing syringes, protective wear, valves, clamps, disposable connectors, etc. Additionally, biopharma plastics are used to manufacture implants for various skin grafting surgeries aimed at reduction, augmentation, and correction of skin.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biopharma plastics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account